Business Wire

The Apollo Group Partners with Oaktree Capital to Facilitate its Next Phase of Growth

Share

The Apollo Group to Leverage 55-Year Track Record to Provide Award-Winning, Full-Service Hospitality Management Services to the Cruise Industry

The Apollo Group (“Apollo” or the “Company”), the leading provider of full-service hospitality management services to the cruise industry, has announced a transformative growth investment from funds managed by Oaktree Capital Management, L.P. ("Oaktree"). Apollo specializes in essential and turnkey hospitality services including crew management, food services, food and beverage distribution, end-to-end procurement and logistics and other related services. This investment will enable Apollo to continue to provide best in class service to its existing customer base while expanding its capabilities in food and beverage distribution.

"As we explored potential investment partners, Oaktree stood out because of its hands on approach and storied history of successful investing in F&B and hospitality management companies," said Jose Ramon Barrera, CEO of Apollo. “Oaktree’s significant capital resources and experience in hospitality management will be critical to achieving Apollo’s strategic growth plan.”

“Apollo Group and its management team have achieved impressive results and established themselves as the go to supplier for hospitality services in the cruise industry. With our investment and partnership, we believe Apollo will be able to significantly expand its footprint and service offering to enhance the value it is already bringing to its blue-chip customer base," said Jared Frandle, Managing Director for Oaktree’s Special Situations Strategy.

“We are very excited to partner with Jose and his team and see significant opportunity for Oaktree to work hand in hand with the Management team to expand Apollo’s capabilities,” said Matt Wilson and Jordon Kruse, Co-Portfolio Managers of Oaktree’s Special Situations Strategy. “The cruise industry has significant tailwinds, and we believe Apollo is well positioned to capitalize given the critical nature of their service offering and leading market position.”

For more information on The Apollo Group, please visit www.theapollogroup.com.

Advisors

Regions Securities LLC served as the exclusive financial advisor to The Apollo Group, and Holland & Knight LLP served as legal advisor to The Apollo Group. Latham & Watkins served as legal advisor to Oaktree.

About The Apollo Group

The Apollo Group is an award-winning, full-service hospitality management company headquartered in Miami, Florida. The Company was founded in 1969 and had been family owned and operated prior to its partnership with Oaktree.

About Oaktree

Oaktree is a leader among global investment managers specializing in alternative investments, with $205 billion in assets under management as of September 30, 2024. The firm emphasizes an opportunistic, value-oriented, and risk-controlled approach to investments in credit, equity, and real estate. The firm has more than 1,200 employees and offices in 23 cities worldwide. For additional information, please visit Oaktree’s website at http://www.oaktreecapital.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250107605076/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy9.1.2025 09:00:00 CET | Press release

Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® (defatted powder of Arachis hypogaea L., semen (peanut)) for thetreatment of toddlers (ages 1 through 3) with a confirmed diagnosis of peanut allergy. The marketing authorisation covers all 27 European member states and the three European Economic Area states (Iceland, Liechtenstein and Norway). This approval of the extension of indication of Palforzia® to toddlers, follows the July 2024 approval by the U.S. Food and Drug Administration (FDA). Palforzia® is the first and only EMA and FDA approved oral immunotherapy for toddlers with a confirmed diagnosis of peanut allergy. “Peanut allergy is one of the most frequent food allergies. Early intervention is crucial to reduce the risks of accidental exposure and may be very important in improving long-term outcomes. The approval of Palforzia for toddl

Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference9.1.2025 08:37:00 CET | Press release

Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that it will present at J.P. Morgan’s 43rd Annual Healthcare Conference on Thursday, January 16, 2025. The company’s presentation will begin at 8:30 a.m. PT/11:30 am (Eastern Time). The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disorders with neurological involvement including GM1/GM2 gangliosidoses and Niemann Pick type C (NPC). Positive topline data reported earlier this year from the company’s successful Phase 2 study investigating nizubaglustat in GM2 and NPC patients demonstrated that the compound had a positive safety profile. Preliminary improvements or stabilization of clinical endpoints were observed in the majority of patients, highlighting encouraging early efficacy trends for the compound. Azafaros is preparing to initiate Phase 3 studies with nizubaglustat in

Kaneka Acquires EndoStream Medical Ltd.9.1.2025 06:21:00 CET | Press release

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) acquired 96.8% of shares of EndoStream Medical Ltd. (Headquarters: Or Akiva, Israel; CEO: Danel Mayer; hereinafter referred to as ESM), an Israeli medical equipment company, on December 23, 2024. By combining Kaneka's manufacturing and ESM's technology, we will jointly develop new medical devices, mainly for cerebrovascular treatment, in addition to the Nautilus™ device for aneurysm treatment currently under development. We aim to achieve sales of over 20 billion yen by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108226003/en/ Cerebral aneurysm treatment device “Nautilus™” (Graphic: Business Wire) ESM is a manufacturer of innovative technologies in the field of cerebrovascular diseases and is developing a device for the treatment of cerebral aneurysms called “Nautilus™” that can treat aneurysms with wide openings in cerebr

KRAFTON Showcases AI Model ‘CPC’ Built with NVIDIA ACE at CES 20259.1.2025 03:37:00 CET | Press release

Shaping the future of gaming with KRAFTON’s AI technology and NVIDIAHands-on demo features CPC technology applied to the PUBG IP Franchise and inZOI KRAFTON (CEO Changhan ‘CH’ Kim) set a new milestone for the global gaming industry with the introduction of ‘CPC’ (Co-Playable Character), an NPC (Non-Player Character) brought to life with generative AI, in collaboration with NVIDIA, at the world’s largest IT exhibition CES 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108628507/en/ Kangwook Lee, Head of the Deep Learning Division at KRAFTON (Photo: KRAFTON) On January 8, KRAFTON joined NVIDIA at the Fontainebleau Hotel in Las Vegas. KRAFTON showcased an innovative AI experience built with NVIDIA ACE technologies, presenting a bold vision for the future of gaming. Kangwook Lee, Head of the Deep Learning Division at KRAFTON, demonstrated CPC, describing it as “a groundbreaking character concept enabled by an on-device

LR Health & Beauty Celebrates Its 40th Anniversary8.1.2025 15:04:00 CET | Press release

Social Commerce Company has been giving sales partners and customers a better quality of life with high-quality product solutions for four decades The Social Commerce Company LR Health & Beauty is looking back on 40 years of company history this year. The company, which was founded in 1985, has developed into a global player in the direct selling industry in recent years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108836518/en/ LR Headquarters (Photo: Business Wire) LR Health & Beauty has been setting innovative trends in the nutritional supplements and cosmetics sector for 40 years. The unique selling point: The products are sold by independent sales partners who earn an additional income by recommending products and setting up their own business. "LR stands for quality, innovation and a strong people business that offers an attractive business model to people who want more flexibility, more self-fulfilment and finan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye